Implantation of an Advanced Practice Nurse in the Complex Care Pathway of Patients Followed for AML Treated With Oral Targeted Therapy
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 主要终点
- Perception of patient
研究概览
简要总结
Advanced Practice Nurse (APN) is a new contributor in the French healthcare system. APN is part of a multidisciplinary team and aim to monitor patients under the coordination of the doctor particularly in onco-hematology. The aim of the study is to describe the different perceptions and expectations of APN monitoring according to patients with acute myeloid leukemia (AML) and their care team.
This study will involve 10 patients, recruited over a provisional period of 5 months and 25 member of care team. Patients and their care team will be asked about their perceptions and expectations of APN participation in (AML monitoring) during a semi-structured interviews.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with AML
- •Treated with a new targeted oral therapy as monotherapy or in combination:
- •Venetoclax* in combination with ivosidenib (IDH1 inhibitor)
- •Onureg* (azacitin: pyrimidine analogue)
- •Venetoclax (BCL-2 protein inhibitor) in combination with subcutaneous azacitin
- •Whose follow-up is provided alternately by a hematologist and an IPA.
- •Affiliated to a social security scheme
排除标准
- •Moderate or severe cognitive impairment
- •Language barrier
- •Other communication disorders
结局指标
主要结局
Perception of patient
时间窗: Within 1 month
Semi-structured interview about perceptions and expectations of Advanced Practice Nurse (APN) participation in acute myeloid leukemia (AML) monitoring according to patient.
次要结局
- Perception of care team(Within 1 month)